Ligand Pharmaceuticals LGND Total costs & expenses

Total costs & expenses at other companies

Royalty PharmaRPRX

$541.02M+46.7%

Ionis PharmaceuticalsIONS

$370.24M+18.6%

Rigel PharmaceuticalsRIGL

$46.93M+15.7%

Opko HealthOPK

$170.55M-21.3%

RegenxbioRGNX

$78.76M-6.9%

Zevra Therapeutics, Inc.ZVRA

$21.05M-13.1%

FAQ

What is Ligand Pharmaceuticals's total costs & expenses?

Ligand Pharmaceuticals (LGND) reported total costs & expenses of $55.1M in Q2 2026.

How has Ligand Pharmaceuticals's total costs & expenses changed year-over-year?

Ligand Pharmaceuticals's total costs & expenses increased by 40.6% year-over-year, from $39.18M to $55.1M.

What is the long-term trend for Ligand Pharmaceuticals's total costs & expenses?

Over 4 years (2021 to 2025), Ligand Pharmaceuticals's total costs & expenses has grown at a 13.3% compound annual growth rate (CAGR), from $137.69M to $227.09M.

What does total costs & expenses mean?

This represents the aggregate sum of all operating and non-operating costs incurred by the company to support its business activities during a specific period. It includes cost of goods sold, research and development, selling, general and administrative expenses, and other operational outlays. This figure is a critical indicator of the company's overall cost structure and operational scale.